ProCE Banner Series

From IV to SC: Managed Care and Clinical Pharmacy Strategies for Integrating Subcutaneous ICI Delivery to Enhance Patient-Centered Care

Live webinar with a managed care and clinical pharmacist discussion on the latest data and clinically relevant information for the safe integration of subcutaneous immune checkpoint inhibitors into the clinic.

  ACPE
Who Should Attend

This activity is intended for pharmacists and other healthcare professionals caring for cancer patients receiving immune checkpoint inhibitors.

All Events

From IV to SC: Managed Care and Clinical Pharmacy Strategies for Integrating Subcutaneous ICI Delivery to Enhance Patient-Centered Care

Upcoming Events

July

23

2025

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Topics

Lung Cancers

Skin Cancers

Genitourinary Cancers

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners' knowledge, competence, and performance in enhancing the comprehensive care of patients with cancer receiving immune checkpoint inhibitor therapies. 

Target Audience
This activity is intended for pharmacists and other healthcare professionals caring for cancer patients receiving immune checkpoint inhibitors. 

Learning Objectives
Upon completion of this event, participants should be able to:

  • Evaluate the benefits and challenges of IV vs SQ ICI routes of administration focusing on patient convenience, HRQoL improvements, healthcare resource utilization, and patient safety
  • Compare efficacy and safety evidence for SQ and IV ICI therapies in patients with cancer across different tumor types and the potential impact of novel delivery systems
  • Integrate comprehensive knowledge of SQ ICI therapies, focusing on effective administration, monitoring for safety and drug-related complications, and coordinating complex treatment regimens to optimize patient-centric care
  • Implement effective multidisciplinary team processes to optimize the implementation of SC administration of ICI therapies into clinical practice based on the latest evidence and individual healthcare system considerations

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-25-164-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and ProCE, LLC.

CCO 2022

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Partners

ProCE, LLC

ProCE Banner

Practicing Clinicians Exchange, LLC

ProCE Banner

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191